Form 6B NTC Viking Global Equities Jun 14, 2022 04:33PM
Form SC 13G Celldex Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP Jun 10, 2022 04:16PM
Cazoo (CZOO) Announces Business Realignment Plan Jun 7, 2022 06:42AM
Form 40-6B/A VIKING GLOBAL INVESTORS Jun 3, 2022 11:34AM
Form SC 13G PepGen Inc. Filed by: VIKING GLOBAL INVESTORS LP May 20, 2022 04:16PM
View Older Stories

May 16, 2022 04:54PM Form 13F-HR VIKING GLOBAL INVESTORS For: Mar 31
May 16, 2022 04:44PM Form 13F-HR/A VIKING GLOBAL INVESTORS For: Sep 30
May 16, 2022 04:34PM Form 13F-HR/A VIKING GLOBAL INVESTORS For: Dec 31
Apr 14, 2022 05:10PM Form SC 13G STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
Apr 11, 2022 07:09AM Ginkgo Bioworks (DNA) and Elanco (ELAN) Launch BiomEdit
Apr 4, 2022 05:32PM Fluidigm (FLDM) Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.
Apr 1, 2022 04:06PM Fluidigm (FLDM) Announces Stockholders Approve $250 Million Strategic Capital Infusion
Mar 29, 2022 09:30AM Fluidigm (FLDM) Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global
Mar 28, 2022 08:33AM Fluidigm (FLDM) Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution
Mar 22, 2022 08:52PM Form 4 PROCEPT BioRobotics Corp For: Mar 18 Filed by: VIKING GLOBAL INVESTORS LP
Mar 22, 2022 05:18PM Form SC 13G/A PROCEPT BioRobotics Corp Filed by: VIKING GLOBAL INVESTORS LP
Mar 4, 2022 05:21PM Form SC 13D/A Ginkgo Bioworks Holdings Filed by: VIKING GLOBAL INVESTORS LP
Mar 4, 2022 07:07AM Form D/A Viking Global Equities
Mar 4, 2022 07:02AM Form D/A Viking Global Equities
Mar 4, 2022 06:57AM Form D/A Viking Global Equities
Feb 18, 2022 05:37AM Fluidigm (FLDM) Reports Q4 Revenue of $38.3M, Net Loss of $0.8M
Feb 14, 2022 06:36PM Form SC 13G/A Athira Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 06:34PM Form SC 13G/A AbCellera Biologics Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 06:34PM Form SC 13G/A Nuance Communications, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 06:25PM Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 06:19PM Form SC 13G/A Edgewise Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:38PM Form SC 13G/A FIGS, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:38PM Form SC 13G/A PMV Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:37PM Form SC 13G/A Rallybio Corp Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:37PM Form SC 13G/A Talaris Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:37PM Form SC 13G/A Coupa Software Inc Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A Adaptive Biotechnologies Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A Orion Acquisition Corp. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A Inhibrx, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A Mudrick Capital Acquisit Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A Pharvaris N.V. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A PROCEPT BioRobotics Corp Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:23PM Form SC 13G Roivant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:23PM Form SC 13G/A Zentalis Pharmaceuticals Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 04:24PM Form 13F-HR VIKING GLOBAL INVESTORS For: Dec 31
Feb 14, 2022 06:11AM Fluidigm (FLDM) Files Prelim Proxy Statement for Proposed $250M Investment from Casdin Capital and Viking Global Investors
Feb 10, 2022 07:13AM Cazoo (CZOO) Raises $630 Million From Investor Group Led by Viking Global Investors
Jan 28, 2022 04:01PM Form 40-6B VIKING GLOBAL INVESTORS
Jan 24, 2022 08:34AM Fluidigm (FLDM) Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.
Jan 21, 2022 05:05PM Form SC 13G Amylyx Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
Jan 18, 2022 04:26PM Form SC 13G Guardant Health, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Jan 13, 2022 09:06PM Form 4 Amylyx Pharmaceuticals, For: Jan 11 Filed by: VIKING GLOBAL INVESTORS LP
Jan 11, 2022 08:47PM Form 3 Amylyx Pharmaceuticals, For: Jan 06 Filed by: VIKING GLOBAL INVESTORS LP
Jan 7, 2022 08:07AM Form D/A Viking Global Opportunit
Jan 7, 2022 08:06AM Form D/A Viking Global Opportunit
Jan 5, 2022 08:20PM Form 4 APi Group Corp For: Jan 03 Filed by: VIKING GLOBAL INVESTORS LP
Jan 5, 2022 05:30PM Form SC 13G/A APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
Dec 21, 2021 05:13AM Sanofi (SNY) Acquires Amunix Immuno-Oncology Pipeline with Next-Gen Conditionally Activated Biologics
Nov 15, 2021 03:55PM Form 13F-HR VIKING GLOBAL INVESTORS For: Sep 30
Oct 15, 2021 04:06PM Form SC 13G TDCX Inc. Filed by: VIKING GLOBAL INVESTORS LP
View Older Stories